Treatment‐Specific Prediction Models in Multiple Myeloma: A Critical Review of Current Evidence and Future Directions

Documenti analoghi

• Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma
  di: Ahmad Y. Abuhelwa, et al.
  Pubblicazione: (2025)
• The Role of Microenvironment in Bispecific Antibodies Treatment in Multiple Myeloma
  di: Serena Barachini, et al.
  Pubblicazione: (2026)
• Outcomes of Melflufen Treatment in Patients With Relapsed/Refractory Multiple Myeloma
  di: Shahrier Hossain, et al.
  Pubblicazione: (2025)
• Venetoclax in the Treatment of Multiple Myeloma: A Retrospective Analysis of 79 Patients
  di: Eli Zolotov, et al.
  Pubblicazione: (2024)
• Improved Outcomes of Myeloma Cast Nephropathy in Newly Diagnosed Multiple Myeloma With Modern Anti‐Myeloma Therapies
  di: Michael Sang Hughes, et al.
  Pubblicazione: (2025)